Emmanuelle Charpentier, Jennifer Doudna and Feng Zhang (張鋒) were named the winners of the second Tang Prize in biopharmaceutical science on Sunday "for the development of CRISPR/Cas 9 as a breakthrough genome editing platform that promises to revolutionize biomedical research and disease treatment."
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
-
Politics
New defense bill threatens payment deadline for U.S. HIMARS: President
05/09/2026 07:22 PM -
Society
Owner faces NT$4,500 fine after pet snake escape on Taipei MRT
05/09/2026 06:31 PM -
Society
Kaohsiung to fine cosmetic surgery chain branches over regulatory violations
05/09/2026 06:11 PM -
Business
CPC to leave gasoline, diesel prices unchanged for next week
05/09/2026 05:21 PM -
Sports
Taipei 101 Run Up draws 5,000 stair climbers from around the globe
05/09/2026 05:13 PM